Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Replimune Group, Inc. Filed by: Ridgeback Capital Investments L.P.

August 14, 2026 4:02 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages used herein are calculated based upon 83,945,161 shares of common stock outstanding as of June 25, 2026, as reported by the Company in its Annual Report on Form 10-K filed with the SEC on June 29, 2026. As of August 13, 2026, the Reporting Person beneficially owned 2,912,373 shares of common stock, or 3.5% of the shares of common stock outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages used herein are calculated based upon 83,945,161 shares of common stock outstanding as of June 25, 2026, as reported by the Company in its Annual Report on Form 10-K filed with the SEC on June 29, 2026. As of August 13, 2026, the Reporting Person beneficially owned 2,912,373 shares of common stock, or 3.5% of the shares of common stock outstanding.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages used herein are calculated based upon 83,945,161 shares of common stock outstanding as of June 25, 2026, as reported by the Company in its Annual Report on Form 10-K filed with the SEC on June 29, 2026. As of August 13, 2026, the Reporting Person beneficially owned 2,912,373 shares of common stock, or 3.5% of the shares of common stock outstanding.


SCHEDULE 13G



Ridgeback Capital Investments L.P.
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:08/14/2026
Ridgeback Capital Investments LLC
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:08/14/2026
Ridgeback Capital Management LLC
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:08/14/2026
Exhibit Information

Exhibit Number 99.1 - Joint Filing Agreement (previously filed)

Categories

SEC Filings